This is the case of the mammalian target of rapamycin (mTOR) inhibitor rapamycin, tested in MND animal models [135] and under investigation in ND patients [136,137], that acts not only on autophagy, but on a plethora of other intracellular pathways. The gene discussed is MTOR; the disease is mild neurocognitive disorder.